Hold Rating Maintained on Edwards Lifesciences Despite Positive SAPIEN 3 Ultra RESILIA Valve Data
Analyst Josh Jennings from TD Cowen maintained a Hold rating on Edwards Lifesciences (EW – Research Report) and keeping the price target at ...
FierceBiotech1h
Abbott completes first-in-human procedures for balloon-expanded TAVR heart implant
Abbott has taken a step forward in the development of a new addition to its structural heart portfolio, completing the first ...
Edwards Lifesciences announces presentation of one-year SAPIEN 3 data
Edwards Lifesciences (EW) announced one-year data highlighting the continued performance of its SAPIEN 3 Ultra RESILIA valve. The data were ...
MassDevice5h
Edwards reports ‘excellent’ outcomes for Sapien 3 Ultra Resilia TAVR system
Edwards Lifesciences (NYSE:EW) today announced one-year data highlighting strong performance from its Sapien 3 Ultra Resilia ...
Edwards Lifesciences announces positive results in one year TAVI trial
Designed for patients needing a replacement valve, the company’s TAVI trial has found low rates of mortality after a year of ...
Le Lézard10h
Edwards' SAPIEN 3 Ultra RESILIA Valve Demonstrates Continued Excellent Outcomes for Patients in Real World Data
Edwards Lifesciences (NYSE: EW) today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3 Ultra RESILIA valve. The data were presented at PCR London Valves 2024 ...
EW ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Notifies Investors Of A Class Action Lawsuit Against Edwards Lifesciences Corporation
Kessler Topaz Meltzer & Check, LLP encourages Edwards investors who have suffered significant losses to contact the firm directly to acquire more information.
bovnews1d
What’s Behind the 0.14% Gain in Edwards Lifesciences Corp (EW) Stock? Find Out Now!
On Friday, Edwards Lifesciences Corp (EW) stock saw a modest uptick, ending the day at $70.48 which represents a slight increase of $0.10 or 0.14% from the prior close of $70.38. The stock opened at ...
ETF Daily News2d
Zacks Research Analysts Reduce Earnings Estimates for EW
Edwards Lifesciences Co. (NYSE:EW – Free Report) – Zacks Research dropped their Q1 2025 EPS estimates for shares of Edwards ...
EW STOCK NEWS: Edwards Lifesciences Stock Plummeted 31% - Contact BFA Law About The Class Action Lawsuit If You Suffered Losses (NYSE:EW)
EW STOCK NEWS: Edwards Lifesciences Stock Plummeted 31% - Contact BFA Law About The Class Action Lawsuit If You Suffered Losses (NYSE:EW) ...
Despite delivering investors losses of 39% over the past 3 years, Edwards Lifesciences (NYSE:EW) has been growing its earnings
For many investors, the main point of stock picking is to generate higher returns than the overall market. But in ...
bovnews3d
The EW Stock Mystery: Why Did EW Surge Today?
On Thursday, Edwards Lifesciences Corp (EW) stock saw a modest uptick, ending the day at $70.38 which represents a slight increase of $0.84 or 1.21% from the prior close of $69.54. The stock opened at ...